Metformin

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

Acupuncture or Metformin for Insulin Resistance in Women With PCOS

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

Pregnancy Outcomes: Effects of Metformin Study (POEM Study)

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Blood Markers of Early Pancreas Cancer

RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer

Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM

Impact of P53 and SIRT1 in Type 2 Diabetes

Vitamin D and Polycystic Ovarian Syndrome (PCOS)

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Impact of Metformin on Immuno-virologic Parameters in HIV

Limiting AAA With Metformin (LIMIT) Trial

Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function

Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance

Extending Time Without Diabetes After Bariatric Surgery: a Trial Comparing the Metformin Addition or Not to Standard Care

Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus

Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS

Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse

Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)

Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide

COAST Therapy in Advanced Solid Tumors and Prostate Cancer

Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes

MetfOrmin BenefIts Lower Extremities With Intermittent Claudication

Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study

Comparison of the Therapeutic Effects of VR and VR + Metformin in the Treatment of Cesarean Section Scar Defect

Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour

Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy

GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes

The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action

Metformin as a Neuroprotective Therapy for Glaucoma

Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)

Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients

Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)

Metformin as Added on Therapy in Patients With Ulcerative Colitis

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia

Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome

Metformin for Fibromyalgia Symptoms (INFORM Trial)

Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes

Phase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma

Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer

PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia

A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy

Efficacy of Injectable Vitamin D Supplementation in Females With Polycystic Ovary Syndrome

Effect of Metformin on Healthy Live Birth in Women With Prediabetes

AMPK-activation by Metformin in FSGS: AMP-FSGS

Preventing Injured Knees From osteoArthritis: Severity Outcomes

Precision Dosing of Metformin in Youth With T2D

Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome

Metformin and Muscle Recovery

Metformin Safety and Efficacy in Osteoarthritis.

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes

Hydroxychloroquine in Type 2 Diabetes During Pregnancy

Metformin Treatment of Patients with Hand Osteoarthritis

Remote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy

Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis

Fish Oil, Metformin and Heart Health in PCOS

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD

Pilot Study on Evaluating the Geroprotective Effect of Metformin

Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)

The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease

Safety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia

Lifestyle Changes in PCOS with OSA and NAFLD

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)

A Cohort Study on the Efficacy of Bariatric Surgery for Rapidly Progressing Diabetic Nephropathy

Glofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCL

HPV Vaccine, Imiquimod, and Metformin Combination Trial

Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemoradiotherapy

Jockey Club Precision Prevention Programme on Young Onset Diabetes

Efficacy of Metformin as an Adjunct to Standard Antidepressant Therapy in Treating Depression Among Obese Patients

A Study of BGM0504 in Participants with Type 2 Diabetes

Liraglutide Treatment in Obese Infertile PCOS Women

Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy

GDM: Insulin with or Without Metformin?

Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopause

Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy

Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use

The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients

Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes

Oral Metformin for Treating Melasma in Latin American Women

The EMPA-FIT Study

Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination

Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label Trial

DM Treatment to Evaluate the Efficacy and Safety of Dapagliflozin or Pioglitazone in Patients with Type 2 Diabetes

Efficacy and Safety of Henagliflozin Proline and Metformin Hydrochloride Extended-release Tablets (Ⅰ) Versus Metformin Tablets in Patients With New-onset Type 2 Diabetes: a Multicenter, Randomized Controlled Study

Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS

Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

Metformin in Safety and Efficacy in Gouty Patients

Metformin in Post Chronic Pancreatitis Diabetes Mellitus

Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes

A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis

Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.

Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients

A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia

Anti-Diabetic Drug, Exercise and Healthy Diet for Knee Osteoarthritis With Overweight/Obesity

Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients

Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis

A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fasting)

A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR3006B", and "BR3006C" in Healthy Adult Volunteers (Fed)

Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation

Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin

Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies

Acute Portal Pressure Reduction by Metformin and Carvedilol Compared to Carvedilol Alone in Cirrhosis.

A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin

Metformin for Premature Infants With Bronchopulmonary Dysplasia

Hyperemesis Gravidarum Risk Reduction With Metformin

Interaction Between Inorganic Nitrate Supplementation and Metformin in Individuals With Prediabetes

Fast In-Bed Tracking (FIT) System Lifestyle Intervention is a Clinical Trial of a Bed Scale Device. Overweight Wheelchair Users Will Complete a Weight Loss Program, Half Get Scales at Baseline, Half at Month 6 Those Who Receive the Bed Scales at Baseline Are Expected to Have Increased Weight Loss

Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome

Metformin Inhibits DNMT3A Clonal Hematopoiesis in Acute Leukemia

Clinical and Biological Signs of Dapagliflozin Overdose in ICU Patients With Metformin Poisoning

Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

Metformin in Parkinson Disease

Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control

Association Between Preoperative Metformin Exposure and Postoperative Nausea and Vomiting in Patients Undergoing General Anesthesia

Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes

Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS?

Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity

Effect of Metformin Use on Weight Loss in Obese, Non-diabetic People (MOWRI)

Lactic Acidosis and Prior Metformin Treatment

Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD

A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin

A Study of LY4515100 in Healthy Participants

PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes Mellitus

A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

Evaluation of the Chemo-preventive Effect of Combined Topical and Systemic Metformin on Oral Leukoplakia

The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment

Glycemic Variability of Combination Therapies in T2DM

A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together

Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma?

Effect of Local Application of 1% Metformin Gel on Implant Stability and Peri-implant Bone Density: A Randomized Controlled Study

Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese Participants

Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke Survivors

Efficay of Physical Activity Program in PCOS Females With Fatty Pancrease and Thyroid Hypofunction

Efficacy of Alpha Lipoic Acid Combined With Myo-Inositol in Non-Diabetic PCOS Patients

Therapeutic Synergy of Probiotic Augmented Conventional Antidiabetic Pharmacotherapy in Gestational Diabetes Mellitus

Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin ± Sulfonylurea/SGLT2 Inhibitor Therapy (UNIGUIDE-2)

Metformin as Adjunct Therapy in Depression-obesity Comorbidity: Clinical and Genetic Evaluation

Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms

An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease

Metformin Effects According to SLC16A11 Carrier Status

The Effect of Empagliflozin and Metformin on Oxidative Capacity and Microvascular Reactivity of Skeletal Muscle in Patients With Type 2 Diabetes Mellitus

Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity

Comparison of Metformin Versus Glyburide for Blood Sugar Control in Women With Gestational Diabetes

Risk-Stratified Management of Inavolisib-Induced Hyperglycemia and Patient Adherence

Effects of Nitraria Retusa Infusion on Clozapine-induced Metabolic Side Effects

Action to Control Cardiovascular Risk in Diabetes (ACCORD)

Diabetes Prevention Program

Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome

Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary Syndrome

Metformin to Treat Obesity in Children With Insulin Resistance

A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)

Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities

Improving Compliance With Metformin

Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)

A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.

A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus

Diabetes Prevention Program Outcomes Study

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione

Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination

Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment

A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics

Treatment of Infertility in Women With Polycystic Ovary Syndrome

Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.

Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)

Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin

Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)

An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024)

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes

Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes

Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy

Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes

Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes

Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes

MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)

The Effects of Metformin on Blood Vessel Structure and Function

Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes

Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)

Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance

Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes

Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet

Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet

Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes

Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone

South Danish Diabetes Study: Evaluation of the Antidiabetic Treatment of Type 2 Diabetes Mellitus

Insulin Resistance and Testosterone in Women

Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)

A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control

The Effects of Calorie Restriction With or Without Metformin on Weight and Insulin Resistance

Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity

Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin

An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus

Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes

Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes

The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus

WelChol® With Metformin in Treating Patients With Type 2 Diabetes

Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients

Lifestyle Intervention and Metformin for Women With Polycystic Ovary Syndrome (PCOS)

Influence of Leg Length Discrepancy on the Spinal Shape and Biomechanics in Functional and Idiopathic Scoliosis Patients

Efficacy and Safety of ATL-962 in Obese Diabetics

Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin

Metformin in Assisted Reproduction-MET-AR-study

PPAR - Combination With Metformin

Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin

Opposing Step-by-step Insulin Reinforcement to Intensified Strategy

Diabetes Prevention Program in Schizophrenia [DPPS]

Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes

Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.

Organic Cation Transporter 1 (OCT1), on Response to Metformin in Healthy Subjects

Genetic Basis for Variation in the Renal Elimination of Metformin

Impact of Genetics on Metformin Pharmacokinetics

Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes

Glitazones and Endothelial Function (GATE)

Glaser Obesity Study

GALLANT 5 Tesaglitazar Versus Metformin

A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS

A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin

A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin

Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes

A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics

Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes

AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus

Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)

GALLANT 8 Tesaglitazar Add-on to Metformin

A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus

ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity

Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational Diabetes

A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin

Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy

Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin

ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus.

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

Life Style Modifications Prevents Type 2 Diabetes in Asian Indians

Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes

Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone

Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control

Impact of Metformin in Teens With Polycystic Ovary Syndrome (PCOS) on Oral Contraceptive Therapy

Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus

Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917

A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone

Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus

Metformin in Non-Alcoholic Fatty Liver Disease

Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes Mellitus

Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes

Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.

A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas

Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Efficacy of Metformin in PCOS: Metabolic and Hormonal Factors

To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together

24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes

Efficacy of Metformin in Lean Women With Polycystic Ovary Syndrome

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin

Patients With Heart Failure ANd Type 2 Diabetes Treated With Placebo Or Metformin (PHANTOM) Pilot Study

A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes

Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study

Exenatide and Metformin Therapy in Overweight Women With PCOS

Insulin Glargine in Type 2 Diabetic Patients

Efficacy and Safety of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes

Acceptability of a Fixed Combination of Fenofibrate and Metformin

Fenofibrate in Dyslipidemia and Metformin-Controlled Diabetes

Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)

Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 Diabetes

Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus

A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes

Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy

AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes

Exenatide Versus Glimepiride in Patients With Type 2 Diabetes

Insulin Glulisine in Type 2 Diabetic Patients

Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment

Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI

Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFO

Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes

Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes

Pegylated-Interferon and Ribavirin Plus Metformin in the Treatment of Chronic HCV Infection and Insulin Resistance

Comparison of Glucovance to Insulin for Diabetes During Pregnancy

Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes

A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial

Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes

Surgical Ovarian Drilling Versus Hormonal Treatment for Infertility Associated to PolyCystic Ovaries Syndrome (PCOS)

RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes

Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes

Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes

Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin

A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. Metformin

Effect of Metformin on Lactate Metabolism

An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.

Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin

Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone

Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone

Simvastatin and Metformin Therapy in PCOS Women. Prospective Randomised Trial.

Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 Diabetes

Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes Patients

Lifestyle Modification and Metformin Use in the Treatment of HIV

Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes

The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study

Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine

Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone

The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory Women

Metformin for the Treatment of Diabetes in Pregnancy

Beta-Cell Function and Sitagliptin Trial (BEST)

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Therapeutic Effects of Berberine in Patients With Type 2 Diabetes

Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes

Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS

Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes

Metformin Suspension and Insulin Sensitivity

Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)

Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin

Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance

Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus

Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.

A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes

Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)

Efficacy of Lifestyle Interventions and Metformin for the Treatment of Antipsychotic-Induced Weight Gain

Metformin and Oral Contraceptives in PCOS

A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects

A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Strategies for Ovulation Induction in Anovulatory Infertile Patients With PCOS

The Effect of Metformin Treatment on Thyroid Hormone Metabolism in Euthyroid Patients With Type 2 Diabetes Mellitus

Japan Early Diabetes Intervention Study

Uterine Artery Blood Flow in Pregnant Women With PCOS Treated With Metformin

A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin

Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes

Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes

Treatment of Anovulatory Infertility in PCOS Patients

12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin

Metformin in Insulin Resistant Left Ventricular (LV) Dysfunction (TAYSIDE Trial)

Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy

Dose-Range Finding Study for MK0893 (0893-008)

Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study

A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)

MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)

Treatment of Hyperglycaemia and Insulin Resistance in HIV Infected Patients

Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin

Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study

Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia

Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs

Safety Study of Pioglitazone Compared To Glyburide on Liver Function

A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes

Vildagliptin 100 mg Once Daily vs. Placebo as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects

Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of Metformin

Metformin in Infertile PCOS Patients

Therapy for Infertile PCOS Patients Ovulating Under Clomiphene Citrate or Metformin

A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.

Short-Term Intensive Insulin Therapy Induction of Long-term Glycemic Control

Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes

Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease

Chronic Inflammatory Activation in Fat Tissue: An Atherogenic Factor in Severe Coronary Artery Disease

Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease

Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes

Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus

A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone

MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066)

Physical Inactivity and Insulin Resistance in Skeletal Muscle.

A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients

Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet

BMS-646256 in Obese and Overweight Type 2 Diabetics

Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)

Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)

MK0767 and Metformin Combination Study (0767-028)

Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025)

Impact of Benfluorex Versus Metformin on Glucose Control and Insulin Secretion in Chinese Type 2 Diabetic Patients

Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)

Treatment Insulin Resistence in HCV G-1 Patient

The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes

Drug Interaction With Metformin

Second-Line Treatments for Anovulatory Infertility in PCOS Patients

The Effect of Adding Metformin to the Treatment of Hepatitis C

Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)

Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes

Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.

Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes Mellitus

52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period

Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM

Investigation Into the Effects Upon Brain Response to Change in Circulating Glucose Levels in Diabetes Mellitus

Genetic Variation in OCT1 and Response to Metformin

Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes

Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes

LoBAG30 Diet in Patients on Metformin

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes

Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes

Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth

Effect of PF-00734200 in Subjects With Type 2 Diabetes

EMPOWIR:Enhance the Metabolic Profile of Women With Insulin Resistance

Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes

Metformin in Amnestic Mild Cognitive Impairment

Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients

Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes

Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients

Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes

Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes

A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator

DZX Mediated Insulin Suppression in Obese Men

A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)

Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride

Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque

A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)

A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin Monotherapy

Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)

Bedtime Insulins and Oral Antihyperglycemic Drugs in Type 2 Diabetes

An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes

An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets

Incretin Secretion in Women With Polycystic Ovary Syndrome (PCOS)

Food Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR 500 mg

Food Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg

Fasting Study of Metformin Hydrochloride ER Tablets 750 mg and Glucophage® XR Tablets 750 mg

Open-label Crossover Metformin Gum Versus Tablet in Healthy Volunteers

Food Study Metformin Hydrochloride ER Tablets 750 mg and Glucophage XR 750 mg

Fasting Study of Glipizide and Metformin HCl Tablets 5 mg/500 mg to Metaglip® Tablets 5 mg/500 mg

Food BE Study Metformin Hydrochloride ER Tablets 500 mg and Glucophage XR 500 mg

Fasting BE Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg

Fasting Study of Metformin Hydrochloride ER Tablets 500 mg and Glucophage® XR Tablets 500 mg

Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus

Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine)

The Copenhagen Insulin and Metformin Therapy Trial

Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients

Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes

A Randomized Double Blind, Placebo Controlled Trial With AMG 108 in Patients With Type 2 Diabetes Mellitus

Standard Medical Management in Secondary Prevention of Ischemic Stroke in China

18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)

Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose Tolerance

How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics

Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

Study of Brain Function in Women With Insulin Resistant Polycystic Ovary Syndrome

A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes

Cardio Risk of Acute Schizophrenia Olanzapine Duke

Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED)

A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin Monotherapy

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes

Risk Reduction in Coronary Heart Disease

Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health

Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients

Metformin in Gestational Diabetes Mellitus

Metformin for the Prevention of the Metabolic Side-effects of Zyprexa

Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)

Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone

Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis

A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin

Sitagliptin in Combination With Metformin and Sulfonylurea

Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 Diabetes

Defective Atypical Protein Kinase C (PKC) Activation in Diabetes and Metabolic Syndrome

Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis

Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes Mellitus

Cortisol Regulation in Polycystic Ovary Syndrome (PCOS)

A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide

The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation

Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics

Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)

Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress

The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus

Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial

A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)

Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin

Pharmacogenetics of Metformin Action in PCOS

A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.

GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)

Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 Diabetes

GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea

Treatment of Adolescent Polycystic Ovary Syndrome (PCOS)

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Metformin in Children With Motor Deficit

MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)

Carotid Atherosclerosis: MEtformin for Insulin ResistAnce Study

Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.

Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione

Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)

A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Plus Pioglitazone.

Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide

BI 10773 add-on to Metformin in Patients With Type 2 Diabetes

Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients

Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin

Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes

Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes

A Study of Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.

A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.

Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.

Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin

Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus

Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone

Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus

Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)

Variation in Serum Levels of Metformin in Patients With Reduced Renal Function

Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.

Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.

Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.

Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes

To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Metformin

Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study

Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA)

Bioequivalence Study of Metformin HCl 750 mg XR Tablets Under Non Fasting Conditions

A Comparitive Bioavailability Study of Metformin Hydrochloride Liquid 500mg/ 5 mL Under Fasting Conditions and After Low and High Fat Meal

Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting Conditions

Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fed Conditions

Bioequivalence Study of Metformin HCl 750 mg XR Under Fasting Conditions